Where is Semma Therapeutics headquartered?

Semma Therapeutics is located in Cambridge, MA.

Who invested in Semma Therapeutics?

Semma Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Semma Therapeutics raised to date?

Semma Therapeutics has raised ____.

When was the last funding round for Semma Therapeutics?

Semma Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

semma-tx.com

Semma Therapeutics

Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes.

Business Model:

Revenue: $7M

Employees: 11-50

Semma Therapeutics was acquired by Vertex Pharmaceuticals.
The acquisition happend on 2019-09-03.
Details of the transaction were not public

Acquirer

Vertex Pharmaceuticals

General Information

Geographic Data

Address: 100 Technology Square

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

series b

Raised Last:

$114M

Raised Total:

$163M

Social

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes.

Contact Phone:
+18575296430

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2017	Venture Round	5	-	F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis
3/2015	Series A	4	$44M	MPM Capital Medtronic F-Prime Capital ARCH Venture Partners MPM Capital
9/2016	Grant		$5M
1/2014	Seed Round	1	-	F-Prime Capital F-Prime Capital
11/2017	Series B		$113.9M	Eight Roads Ventures Cowen Healthcare Investments Medtronic MPM Capital F-Prime Capital Partners ARCH Venture Partners Novartis JDRF
11/2017	Series B		$0	6 Dimensions Capital ARCH Venture Partners Cowen Group Eight Roads Ventures F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis ORI Capital Sinopharm Capital Wu Capital 6 Dimensions Capital ARCH Venture Partners Cowen Group Eight Roads Ventures F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis ORI Capital Sinopharm Capital Wu Capital
11/2017	Series B	12	$114M	6 Dimensions Capital ARCH Venture Partners Cowen Group Eight Roads Ventures F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis ORI Capital Sinopharm Capital Wu Capital 6 Dimensions Capital ARCH Venture Partners Cowen Group Eight Roads Ventures F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis ORI Capital Sinopharm Capital Wu Capital
3/2017	Venture Round	5	-	F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis F-Prime Capital JDRF T1D Fund Medtronic MPM Capital Novartis
1/2014	Seed Round	1	-

Acquisitions

Announced Date	Name	Price
11/2015	CytoSolv

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details